Restoration of Endothelial Function in Pparα (−/−) Mice by Tempol

Por Silswal, Neerupma, Parelkar, Nikhil, Andresen, Jon, Wacker, Michael J.
Publicado no PPAR Res (2015)

RESVERATROL DOWNREGULATES BIOMARKERS OF SEPSIS VIA INHIBITION OF PROTEASOME’S PROTEASES

Por Silswal, Neerupma, Reddy, Nidhi S., Qureshi, Asaf A., Qureshi, Nilofer
Publicado no Shock (2018)

Of Mice and Men: Proteasome's Role in LPS-Induced Inflammation and Tolerance

Por Silswal, Neerupma, Reis, Julia, Qureshi, Asaf A., Papasian, Christopher, Qureshi, Nilofer
Publicado no Shock (2017)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists

Por Silswal, Neerupma, Parelkar, Nikhil K., Wacker, Michael J., Badr, Mostafa, Andresen, Jon
Publicado em 2012

Evaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed Humans

Por Qureshi, Asaf A, Khan, Dilshad A, Silswal, Neerupma, Saleem, Shahid, Qureshi, Nilofer
Publicado no J Clin Exp Cardiolog (2016)

2,2,2-Trichloroethanol Activates a Nonclassical Potassium Channel in Cerebrovascular Smooth Muscle and Dilates the Middle Cerebral Artery

Por Parelkar, Nikhil K., Silswal, Neerupma, Jansen, Kirsten, Vaughn, Joshua, Bryan, Robert M., Andresen, Jon
Publicado em 2010

Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs

Por Qureshi, Asaf A., Zuvanich, Eleanor G., Khan, Dilshad A., Mushtaq, Shahida, Silswal, Neerupma, Qureshi, Nilofer
Publicado no Lipids Health Dis (2018)

Skeletal Muscle, but not Cardiovascular Function, Is Altered in a Mouse Model of Autosomal Recessive Hypophosphatemic Rickets

Por Wacker, Michael J., Touchberry, Chad D., Silswal, Neerupma, Brotto, Leticia, Elmore, Chris J., Bonewald, Lynda F., Andresen, Jon, Brotto, Marco
Publicado no Front Physiol (2016)

FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability

Por Silswal, Neerupma, Touchberry, Chad D., Daniel, Dorothy R., McCarthy, Darla L., Zhang, Shiqin, Andresen, Jon, Stubbs, Jason R., Wacker, Michael J.
Publicado em 2014

Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB

Por Touchberry, Chad D, Silswal, Neerupma, Tchikrizov, Vladimir, Elmore, Christopher J, Srinivas, Shubra, Akthar, Adil S, Swan, Hannah K, Wetmore, Lori A, Wacker, Michael J
Publicado no BMC Pharmacol Toxicol (2014)

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

Por Grabner, Alexander, Schramm, Karla, Silswal, Neerupma, Hendrix, Matt, Yanucil, Christopher, Czaya, Brian, Singh, Saurav, Wolf, Myles, Hermann, Sven, Stypmann, Jörg, Di Marco, Giovana Seno, Brand, Marcus, Wacker, Michael J., Faul, Christian
Publicado no Sci Rep (2017)

Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms

Por Carson, Ross A., Rudine, Anthony C., Tally, Serena J., Franks, Alexis L., Frahm, Krystle A., Waldman, Jacob K., Silswal, Neerupma, Burale, Suban, Phan, James V., Chandran, Uma R., Monaghan, A. Paula, DeFranco, Donald B.
Publicado no PLoS One (2018)